141 related articles for article (PubMed ID: 26255146)
21. Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.
Bloom AS; Edgemond WS; Moldvan JC
Neurochem Res; 1997 May; 22(5):563-8. PubMed ID: 9131634
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
Twitchell W; Brown S; Mackie K
J Neurophysiol; 1997 Jul; 78(1):43-50. PubMed ID: 9242259
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Apr; 159(8):1608-22. PubMed ID: 20233228
[TBL] [Abstract][Full Text] [Related]
25. Do cannabinoids exhibit a tyramine-like effect?
Ilayan E; Feliszek M; Malinowska B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1041-6. PubMed ID: 23900610
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Nov; 152(5):717-24. PubMed ID: 17700721
[TBL] [Abstract][Full Text] [Related]
28. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
29. Anandamide Reduces the Toxic Synergism Exerted by Quinolinic Acid and Glutaric Acid in Rat Brain Neuronal Cells.
Kotlar I; Rangel-López E; Colonnello A; Aguilera-Portillo G; Serratos IN; Galván-Arzate S; Pedraza-Chaverri J; Túnez I; Wajner M; Santamaría A
Neuroscience; 2019 Mar; 401():84-95. PubMed ID: 30668975
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
Scutt A; Williamson EM
Calcif Tissue Int; 2007 Jan; 80(1):50-9. PubMed ID: 17205329
[TBL] [Abstract][Full Text] [Related]
31. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of monoamine oxidase activity by cannabinoids.
Fisar Z
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):563-72. PubMed ID: 20401651
[TBL] [Abstract][Full Text] [Related]
34. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes.
Venance L; Piomelli D; Glowinski J; Giaume C
Nature; 1995 Aug; 376(6541):590-4. PubMed ID: 7637807
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.
Mendiguren A; Pineda J
Neurosci Lett; 2004 Jun; 363(1):1-5. PubMed ID: 15157983
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.
Hayase T; Yamamoto Y; Yamamoto K
J Pharm Pharmacol; 2001 Nov; 53(11):1525-32. PubMed ID: 11732755
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
38. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.
Athanasiou A; Clarke AB; Turner AE; Kumaran NM; Vakilpour S; Smith PA; Bagiokou D; Bradshaw TD; Westwell AD; Fang L; Lobo DN; Constantinescu CS; Calabrese V; Loesch A; Alexander SP; Clothier RH; Kendall DA; Bates TE
Biochem Biophys Res Commun; 2007 Dec; 364(1):131-7. PubMed ID: 17931597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]